These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7287228)

  • 1. Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity.
    Herlyn DM; Koprowski H
    Int J Cancer; 1981 Jun; 27(6):769-74. PubMed ID: 7287228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tumorigenicity and resistance to antibody lysis of human colon tumor cells xenografted in congenitally athymic mice.
    Tompkins MB; Rama Rao GV; Tompkins WA
    Cancer Res; 1979 Jun; 39(6 Pt 1):2160-5. PubMed ID: 445413
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
    Drebin JA; Link VC; Greene MI
    Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of monoclonal antibodies to small cell lung cancer.
    Okabe T; Kaizu T; Fujisawa M; Watanabe J; Takaku F
    Jpn J Med; 1985 Aug; 24(3):250-6. PubMed ID: 2999485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells.
    Barr IG; Miescher S; von Fliedner V; Buchegger F; Barras C; Lanzavecchia A; Mach JP; Carrel S
    Int J Cancer; 1989 Mar; 43(3):501-7. PubMed ID: 2647641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase-augmented anticarcinoembryonic antigen (CEA)-complement lysis of human colon tumor cells: lack of correlation with anti-CEA-mediated K-cell lysis and iodine-125 binding.
    Tompkins WA; Schmale JD; Mock R; Tick NT; Lock T; Sidell N; Palmer JL
    J Natl Cancer Inst; 1979 Mar; 62(3):503-11. PubMed ID: 283279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enhancing effect by anti-cancer drugs on growth inhibition of colon carcinoma in nude mice by monoclonal antibody and complement].
    Sakita M; Hata K; Iwamoto A; Kitamura K; Suzuyama H; Takahashi T
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):999-1006. PubMed ID: 2778387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
    Hellström I; Beaumier PL; Hellström KE
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7059-63. PubMed ID: 3462743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
    Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
    Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA; Schreiber GJ; Cosand WL; Raff HV
    Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
    Naundorf S; Preithner S; Mayer P; Lippold S; Wolf A; Hanakam F; Fichtner I; Kufer P; Raum T; Riethmüller G; Baeuerle PA; Dreier T
    Int J Cancer; 2002 Jul; 100(1):101-10. PubMed ID: 12115595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses in human colon cancer. II. Cytotoxic antibody detected in patients' sera.
    Hahn WV; Kagnoff MF; Hatlen LH
    J Natl Cancer Inst; 1978 Apr; 60(4):779-84. PubMed ID: 75979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
    Carrel S; Delisle MC; Mach JP
    Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.